Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study
Kateryna V. Miroshnychenko, Anna V. Shestopalova
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 19, pp. 8672-8686
Open Access | Times Cited: 15

Showing 15 citing articles:

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
Amal Mahmoud, Ahmed Mostafa, Ahmed A. Al‐Karmalawy, et al.
Heliyon (2021) Vol. 7, Iss. 9, pp. e07962-e07962
Open Access | Times Cited: 79
Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid
Xifeng Xiong, Nan Tang, Xudong Lai, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 69
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25
The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
Iqrar Ahmad, Rahul Pawara, Sanjay J. Surana, et al.
Topics in Current Chemistry (2021) Vol. 379, Iss. 6
Open Access | Times Cited: 48
Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin
Samuel K. Kwofie, Emmanuel Broni, Seth O. Asiedu, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 406-406
Open Access | Times Cited: 45
Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations
Soodeh Mahdian, Mahboobeh Zarrabi, Yunes Panahi, et al.
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100541-100541
Open Access | Times Cited: 31
Screening of world approved drugs against highly dynamical spike glycoprotein of SARS-CoV-2 using CaverDock and machine learning
Gaspar Pinto, Ondřej Vávra, Sérgio M. Marques, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 3187-3197
Open Access | Times Cited: 17
Corilagin and 1,3,6-Tri-O-galloy-β-d-glucose: potential inhibitors of SARS-CoV-2 variants
Vincent Binette, Sébastien Côté, Mohamed Haddad, et al.
Physical Chemistry Chemical Physics (2021) Vol. 23, Iss. 27, pp. 14873-14888
Open Access | Times Cited: 14
Potential of amentoflavone with antiviral properties in COVID-19 treatment
Akhilesh Vikram Singh
Asian Biomedicine (2021) Vol. 15, Iss. 4, pp. 153-159
Open Access | Times Cited: 13
Antioxidant and anticholinesterase activities of amentoflavone isolated fromOuratea fieldingiana(Gardner) Engl. throughin vitroand chemical-quantum studies
Lucas Soares Frota, Daniela Ribeiro Alves, Márcia Machado Marinho, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 41, Iss. 4, pp. 1206-1216
Closed Access | Times Cited: 8
Composição química e avaliação das atividades antioxidante e anticolinesterásica do óleo dos frutos de Ouratea fieldingiana (Gargner) Engl.
Lucas Soares Frota, Francisco Flávio da Silva Lopes, Daniela Ribeiro Alves, et al.
Research Society and Development (2021) Vol. 10, Iss. 10, pp. e532101019013-e532101019013
Open Access | Times Cited: 6
Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review
Mohan Singh, Nidhi Singh, Divya Mishra, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 33, pp. 2601-2617
Closed Access | Times Cited: 2
Wolbachia Ferrochelatase as a potential drug target against filarial infections
Cephas Biney, Grazia Edumaba Graham, Ebenezer Asiedu, et al.
Journal of Molecular Graphics and Modelling (2023) Vol. 122, pp. 108490-108490
Closed Access
Computational studies suggest compounds restoring function of p53 cancer mutants can bind SARS-CoV-2 spike protein
Tanushree Das, Chaitali Mukhopadhyay
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 8, pp. 3368-3381
Closed Access
Page 1

Scroll to top